July 2019 - Sperling Prostate Center

Androgen Deprivation Therapy and Radiation: A Synergistic Effect

There is a saying from the world of computer programming: “Theory is when you know something, but it doesn’t work. Practice is when something works, but you don’t know why.” This saying also captures something that mystified urology/radiation oncology teams for two decades. Androgen deprivation therapy (ADT) boosts the effectiveness of radiation therapy as a keep reading

Stereotactic Body Radiation Therapy: Quality of Life vs. Possible Risks

The evolution of prostate cancer (PCa) treatment often seems like a moving target. Suddenly there’s a revolutionary new treatment, or an exciting development in an existing one. Patients benefit from technological advances, gains in experience, and improved scientific knowledge—but even the most promising must survive the test of time, since unintended consequences can show up keep reading

A PROMIS is a Promise for Multiparametric MRI

In the world of prostate cancer (PCa) diagnosis, the year 2017 began with the January 19 online publication of another brilliant study out of the University College London and other British centers of clinical research.[i] The study, called PROMIS, was a comparison between multiparametric MRI (mpMRI) vs. TRUS biopsy in terms of diagnostic accuracy. Actually, keep reading

Month: July 2019

Androgen Deprivation Therapy and Radiation: A Synergistic Effect

Stereotactic Body Radiation Therapy: Quality of Life vs. Possible Risks

A PROMIS is a Promise for Multiparametric MRI